Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00011141
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2001-02-12
Brief Title:
Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency
Sponsor:
National Center for Research Resources NCRR
Organization:
National Center for Research Resources NCRR
Study Overview
Official Title:
Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency
Status:
COMPLETED
Status Verified Date:
2003-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The etiology of immune-mediated diabetes mellitus IMD remains unclear However previous studies indicate that autoimmunity may be a result of dysfunction of natural killer T cells NK-T cells Newly diagnoses patients with IMD have been shown in our laboratory to have significantly lower NK-T cells than normal controls Other studies have shown that oral administration of lactobacillus can boost NK-T cell activity in children with HIV without side effects Our objective is to evaluate the effect of lactobacillus administration on NK-T cell activity in patients with IMD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: